JPRN-UMIN000013636已完成未知
Phase I/II trial of neoadjuvant intravenous gemcitabine plus intra-arterial cisplatin in muscle-invasive bladder cancer. - Phase I/II trial of neoadjuvant intravenous gemcitabine plus intra-arterial cisplatin in muscle-invasive bladder cancer.
ippon Medical School Musashokosugi Hospital0 个研究点目标入组 20 人开始时间: 2014年4月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. women who are pregnant, possibly pregnant or lactating 2.pleural effusion, peritoneal effusion or pericardial effusion which need emergency treatment 3.presence of active infection 4.presence of active double cancer 5.history of drug hypersensitivity reaction 6.presence of severe complication 7.presence of bilateral hydronephrosis (other than the case which was treated by ureteral stent or nephrostomy ) 8.patients inapprppriate for the study entry determined by a doctor
研究者
相似试验
招募中
2 期
A Phase II trial of neoadjuvant therapy with GEM/IMRT for potentially resectable pancreatic cancerpotentially resectable pancreatic cancerJPRN-UMIN000022303Kyoto University60
招募中
2 期
A phase II clinical trial of neoadjuvant gemcitabine and S-1 with concurrent radiotherapy in patients with resectable and borderline resectable pancreatic ductal adenocarcinomaresectable and borderline resectable (BR-PV) pancreatic cancerJPRN-UMIN000053195Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University64
招募中
2 期
A phase II clinical trial of neoadjuvant gemcitabine and S-1 with concurrent hypofractionated radiotherapy in patients with resectable and borderline resectable pancreatic ductal adenocarcinomaresectable and borderline resectable (BR-PV) pancreatic cancerJPRN-UMIN000038585Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University54
招募中
2 期
Randomized phase II trial of neoadjuvant Gemcitabine/S-1 based chemoradiotherapy for potentially resectable pancreatic ductal adenocarcinomainvasive pancreatic ductal adenocarcinomainvasive pancreatic ductal adenocarcinoma, potentially resectable pancreatic cancerJPRN-jRCTs041200079Mizuno Shugo70
已完成
不适用
Feasibility study of neoadjuvant gemcitabine plus nab-paclitaxel for borderline resectable pancreatic cancerBorderline resectable pancreatic cancerJPRN-UMIN000023591Kyorin University, School of Medicine10